Safety and Pharmacokinetic Comparison of Cilostazol SR and IR Formulations in Healthy Korean Volunteers
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study investigates safety and pharmacokinetic comparison of Pacific Pharma's PP-101 SR
(test formulation) and Otsuka's Pletaal® IR (reference formulation) for single and multiple
doses and food effects on Pacific Pharma's PP-101 SR in healthy volunteers.